DePrince Race & Zollo Inc (DRZ)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-662,902
| Closed | -$22M | – | 265 |
|
2017
Q2 | $22M | Buy |
662,902
+4,307
| +0.7% | +$143K | 0.45% | 108 |
|
2017
Q1 | $21.1M | Sell |
658,595
-136,779
| -17% | -$4.39M | 0.44% | 115 |
|
2016
Q4 | $28.8M | Buy |
795,374
+202,650
| +34% | +$7.35M | 0.56% | 89 |
|
2016
Q3 | $27.3M | Buy |
592,724
+26,640
| +5% | +$1.23M | 0.58% | 88 |
|
2016
Q2 | $28.4M | Buy |
566,084
+486,894
| +615% | +$24.5M | 0.58% | 93 |
|
2016
Q1 | $4.24M | Buy |
+79,190
| New | +$4.24M | 0.09% | 159 |
|
2015
Q1 | – | Sell |
-18,630
| Closed | -$1.07M | – | 299 |
|
2014
Q4 | $1.07M | Sell |
18,630
-5,700
| -23% | -$328K | 0.01% | 257 |
|
2014
Q3 | $1.31M | Sell |
24,330
-837,201
| -97% | -$45M | 0.02% | 257 |
|
2014
Q2 | $45.2M | Sell |
861,531
-47,200
| -5% | -$2.47M | 0.53% | 80 |
|
2014
Q1 | $48M | Sell |
908,731
-189,920
| -17% | -$10M | 0.58% | 69 |
|
2013
Q4 | $44M | Sell |
1,098,651
-125,300
| -10% | -$5.02M | 0.56% | 70 |
|
2013
Q3 | $46.2M | Buy |
1,223,951
+47,633
| +4% | +$1.8M | 0.63% | 57 |
|
2013
Q2 | $46.1M | Buy |
+1,176,318
| New | +$46.1M | 0.63% | 56 |
|